FDA Spokesperson - ARCHIVED
@FDASpox_Archive
Assistant Commissioner for Media Affairs, U.S. Food and Drug Administration. - ARCHIVED ACCOUNT
ID:1010212748029022208
https://www.fda.gov/ 22-06-2018 17:27:42
1,0K Tweets
2,4K Followers
409 Following
.Dr. Stephen M. Hahn: President Biden wants us to be focused on urgency. 'I have great faith in the 17,000 FDA employees who are terrific scientists, doctors, and nurses that we’re going to do that and move it forward for the American people. That's our promise to them.”
“FDA completely supports clinical trial performance because at the end of the day, clinical trials—particularly randomized clinical trials—provide gold standard information.” -- Dr. Stephen M. Hahn
'I personally could have done a better job and should have done a better job at that press conference explaining what the data show regarding convalescent plasma. I can assure the American people that this decision was made based upon sound science and data.' — Dr. Stephen M. Hahn
Commissioner Dr. Stephen M. Hahn on CBS Mornings today: 'The Mayo Clinic convalescent plasma program has shown that there are promising efficacy data as well as safety associated with plasma.'
Professionals & scientists at FDA independently made this decision with his support, he said.
Tune in 8am ET Tuesday morning for Dr. Stephen M. Hahn on CBS Mornings to talk about the benefits of convalescent plasma treatment for COVID patients in hospital and more.